Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
Blood Neoplasia|July 2, 2025
Outcomes at a single institution with MTR induction and consolidation in the management of primary CNS lymphomaNikita K Dave, Veronica Carvajal, Alex C Watts, et al.
Nature Communications|February 15, 2019
Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansionMarilia Rita Pinzone, D Jake VanBelzen, Sam Weissman, et al.
The Journal of Molecular Diagnostics : JMD|August 28, 2021
Optimization of Sources of Circulating Cell-Free DNA Variability for Downstream Molecular AnalysisJacob E Till, Taylor A Black, Caren Gentile, et al.
Molecular Therapy. Methods & Clinical Development|January 29, 2024
Long-term stability of clinical-grade lentiviral vectors for cell therapyJulie K Jadlowsky, Rachel Leskowitz, Stephen McKenna, et al.
Science Translational Medicine|May 4, 2012
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cellsJohn Scholler, Troy L Brady, Gwendolyn Binder-Scholl, et al.
Contemporary Clinical Trials|January 7, 2015
Women In Steady Exercise Research (WISER) Sister: study design and methodsKathryn H Schmitz, Nancy I Williams, Despina Kontos, et al.
Breast Cancer Research and Treatment|October 30, 2015
Dose-response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trialKathryn H Schmitz, Nancy I Williams, Despina Kontos, et al.
Blood Advances|December 10, 2024
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysisPeter A Riedell, Connor B Grady, Loretta J Nastoupil, et al.
The New England Journal of Medicine|September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaAlfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2020
Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic LeukemiaNoelle V Frey, Saar Gill, Elizabeth O Hexner, et al.
Pageof 24